BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10811315)

  • 1. Retreatment of hepatitis C patients who do not respond to interferon: the search continues.
    Pianko S; McHutchison J
    Am J Gastroenterol; 2000 May; 95(5):1122-4. PubMed ID: 10811315
    [No Abstract]   [Full Text] [Related]  

  • 2. Ribavirin approved with a big fat price.
    Falkenberg J
    Notes Undergr; 1998; (No 37):10-1. PubMed ID: 11365818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C: new treatment overview.
    Stoia J
    AIDS Treat News; 1998 Sep; (302):5-6. PubMed ID: 11365763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of anxiolytics and antidepressants before and after treatment with interferon-alpha and ribavirin in patients with hepatitis C].
    García-Toro M; Vilella Martorell A; Carral Martínez M; Jimeno Beltrán T; Román Ruiz del Moral Y; Pradas Guerrero C; Gili Planas M; Roca Bennasar M
    Gastroenterol Hepatol; 2011 Apr; 34(4):307-8. PubMed ID: 21376422
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of low-dose intermittent interferon-alpha monotherapy in patients infected with hepatitis C virus genotype 1b who were predicted or failed to respond to pegylated interferon plus ribavirin combination therapy.
    Akuta N; Suzuki F; Kawamura Y; Yatsuji H; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2008 Aug; 80(8):1363-9. PubMed ID: 18551610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribavirin and interferon for recurrent posttransplantation HCV infection: to treat or not to treat?
    McHutchison JG
    Hepatology; 1997 Aug; 26(2):505-6. PubMed ID: 9252167
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin].
    Vega Palomares R; Planas Vilà R; Durández Lazaro R; Fábregas Puigtió S
    Gastroenterol Hepatol; 2002 Oct; 25(8):483-6. PubMed ID: 12361528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C in 2012.
    Lemon M
    S D Med; 2012 Nov; 65(11):432-3. PubMed ID: 23189411
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment of hepatitis C: history, presence and future.
    Vrolijk JM; de Knegt RJ; Veldt BJ; Orlent H; Schalm SW
    Neth J Med; 2004 Mar; 62(3):76-82. PubMed ID: 15209471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy for hepatitis C.
    TreatmentUpdate; 1998 Mar; 10(1):2-3. PubMed ID: 11365430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy with interferon plus ribavirin in hemodialysis patient with PCR-positive viral hepatitis C].
    Arambarri M; Fernández Lucas M; Echarri R; Teruel JL; Alarcón C; Merino JL; Ortuño J
    Nefrologia; 2004; 24 Suppl 3():39-42. PubMed ID: 15219067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of ribavirin mutagenicity in human hepatitis C virus infection.
    Chevaliez S; Brillet R; Lázaro E; Hézode C; Pawlotsky JM
    J Virol; 2007 Jul; 81(14):7732-41. PubMed ID: 17494069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chronic hepatitis C virus infection with interferon alfa and ribavirin: sustained response in two patients with transfusion dependent thalassaemia.
    Hamidah A; Yong JF; Zulkifli HI; Jamal R
    Med J Malaysia; 2002 Sep; 57(3):353-6. PubMed ID: 12440276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic hepatitis C with amantadine hydrochloride in patients who had not responded to previous treatment with interferon-alpha and/or ribavirin.
    Di Martino V; Boudjema H; Delacour T; Cazier A; Caron C; Coutarel P; Dumouchel P; Cadranel JF
    Clin Infect Dis; 2001 Mar; 32(5):830-1. PubMed ID: 11229855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of chronic hepatitis C: present and future].
    Hezode C; Dhumeaux D
    Gastroenterol Clin Biol; 2000 May; 24(5):533-5. PubMed ID: 10891741
    [No Abstract]   [Full Text] [Related]  

  • 16. A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C.
    Shakil AO; McGuire B; Crippin J; Teperman L; Demetris AJ; Conjeevaram H; Gish R; Kwo P; Balan V; Wright TL; Brass C; Rakela J
    Hepatology; 2002 Nov; 36(5):1253-8. PubMed ID: 12395337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon and ribavirin versus interferon and amantadine in interferon nonresponders with chronic hepatitis C.
    Khalili M; Denham C; Perrillo R
    Am J Gastroenterol; 2000 May; 95(5):1284-9. PubMed ID: 10811340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual hepatitis B virus and hepatitis C virus infection: To treat or not to treat, and how?
    Husa P
    J Gastroenterol Hepatol; 2005 May; 20(5):669-70. PubMed ID: 15853976
    [No Abstract]   [Full Text] [Related]  

  • 19. [Retreatment of patients with chronic hepatitis C].
    Ostojić R
    Acta Med Croatica; 2005; 59(5):447-51. PubMed ID: 16381242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of hepatitis C virus quasispecies during therapy with IL2 combinated to alpha interferon and ribavirin.
    Boulestin A; Sandres-Saune K; Alric L; Pipy B; Dubois M; Vinel JP; Izopet J
    Antivir Ther; 2005; 10(4):499-504. PubMed ID: 16038475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.